{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-123305","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2025-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.069500+00:00","generated_at":"2026-05-16T12:35:11.641062+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NextCure enters ATM agreement for up to $14.5M common stock offering with H.C. Wainwright","bullets":["ATM agreement allows sale of up to $14.5M of common stock at market prices, effective December 19, 2025.","Agent H.C. Wainwright receives 3.0% compensation on gross proceeds from shares sold.","Net proceeds to fund general corporate purposes, including preclinical studies and clinical trials.","Sales may be made on Nasdaq or in negotiated transactions; no minimum price or volume commitments."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-123305","json":"https://secwatch.observer/filing/0001104659-25-123305.json","markdown":"https://secwatch.observer/filing/0001104659-25-123305.md","text":"https://secwatch.observer/filing/0001104659-25-123305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000110465925123305/0001104659-25-123305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000110465925123305/tm2533962d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:35:11.641062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}